HSIC — Henry Schein price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Key stats#
Data provided bySource: Twelve DataPrice data
- Price
- $86.22
- YTD price return
- +14.08%
- YTD total return
- +14.08%
- Market cap
- 9.5B
- Enterprise value
- 13.9B
- Shares outstanding
- 110.5M
- 52W low
- $68.70
- 52W high
- $92.18
- From 52W high
- -6.47%
- From 52W low
- +25.50%
- 52W range
- 75%$68.70–$92.18
- Beta
- 0.80
Volume
- Rel volume
- 1.42×
- 30D volume
- 1.5M
- 30D $ vol
- 131.3M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- none
- Insider net 1Y
- −$7.9M
Form 4 transactions by trade date, as filed; latest on file 2026-05-11.
Fundamentals
- Sales (ttm)
- 13.7B
- Sales/share
- $124.25
- EPS (ttm)
- $3.65
- FCF (ttm)
- 559M
- FCF/share
- $5.06
- Book value/share
- $28.58
- Net margin
- 3.07%
- ROE
- 13.33%
- ROA
- 3.66%
- Debt / equity
- 0.75×
- Current ratio
- 1.33
Growth (CAGR, ttm) · 10Y
- Sales
- +6.17%+2.67%+2.34%+1.97%
- Net income
- +7.70%-1.84%-7.65%-1.66%
- FCF
- +38.87%-4.87%-5.01%-0.24%
- Shares
- -6.12%-5.26%-4.43%-3.69%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +15.38%+2.95%-3.67%+1.93%
- Sales/share
- +13.10%+8.38%+7.08%+5.87%
- FCF/share
- +47.93%+0.42%-0.61%+3.51%
- Book value/share
- +0.10%+0.57%+2.76%+4.74%
- Price
- +17.58%+8.50%+1.70%+3.45%
- Total return
- +17.58%+8.50%+1.70%+3.45%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 23.6×
- P/OI (ttm)
- 13.4×
- Fwd P/E
- 14.3×
- P/S (ttm)
- 0.7×
- P/B (mrq)
- 3.0×
- P/FCF (ttm)
- 17.0×
- EV/EBITDA (fy)
- 13.3×
- EV/Sales (ttm)
- 1.0×
- FCF yield (ttm)
- 5.87%
- Buyback yield (realized, 1y)
- 6.12%
- Shareholder yield (realized, 1y)
- 6.12%
- Buyback yield (cash, ttm)
- 6.82%
- Shareholder yield (cash, ttm)
- 6.82%
Vs own 10Y history
- P/E
- 74th
- P/OI
- 38th
- P/S
- 17th
- P/B
- 53rd
- P/FCF
- 39th
Bar = where today’s multiple sits in HSIC’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).
Performance · price returntotal return · as of 2026-11-13#
Data provided bySource: Twelve DataFundamentals#
Operating income
5Y CAGR +4.1%10Y CAGR −1.2%YoY +17.7%EPS (diluted)
5Y CAGR +3.0%10Y CAGR +1.4%YoY +26.2%Free cash flow
5Y CAGR +0.8%10Y CAGR +0.5%YoY −7.1%TTM: operating cash flow $687M, capex −$128M
Q3 2026: operating cash flow $161M, capex −$30M
Shares (diluted)
5Y −15.1%10Y −27.7%YoY −7.0%Net income
5Y CAGR −0.3%10Y CAGR −1.8%YoY +17.8%About Henry Schein#
Data provided bySource: Twelve DataHenry Schein, Inc. is a health care solutions company that serves office-based dental, medical, and veterinary professionals. Henry Schein provides a broad range of products and services through its core businesses in healthcare distribution, specialty products, and technology-enabled value-added services. Its offerings include consumable supplies, dental equipment, practice-management software, logistics support, and related clinical solutions that help practices manage daily operations more efficiently. The company also supports dental laboratories, government and institutional health care clinics, and other alternate care sites with products and services tailored to professional workflows. With a strong presence in dental and medical markets, Henry Schein plays an important role in the supply chain for outpatient health care providers and practice support services.
Melville, NY·25,000 employees·Medical Distribution·henryschein.com·As of Oct 28, 2026
Recent filings#
- Nov 3Earnings · Earnings release — EPS $1.56 vs $1.34 est. (+16.4%); revenue $3.47B (+4% y/y) 4.8%
- Oct 88-K · Henry Schein Announces Chief Financial Officer Leadership Transition
- Aug 4Earnings · Earnings release — EPS $1.27 vs $1.22 est. (+4.1%); revenue $3.46B (+7% y/y) 3.0%
- Jul 308-K · Henry Schein Announces Leadership Transitions
ETFs holding HSIC#
28 of the 193 ETFs ChartRow carries live hold HSIC. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| RSP | Invesco S&P 500 Equal Weight ETF | 0.2% |
| VBR | Vanguard Small-Cap Value ETF | 0.2% |
| XLV | Health Care Select Sector SPDR Fund | 0.1% |
| VHT | Vanguard Health Care ETF | 0.1% |
| VB | Vanguard Small-Cap ETF | 0.1% |
| IWS | iShares Russell Mid-Cap Value ETF | 0.1% |
| IWR | iShares Russell Midcap ETF | 0.1% |
| SPYV | SPDR Portfolio S&P 500 Value ETF | 0.0% |
Related Healthcare#
Data provided bySource: Twelve Data| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +23.75% | +1.14% |
| JNJ | Johnson & Johnson | +14.94% | +0.79% |
| ABBV | AbbVie Inc. | +7.53% | +0.20% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +7.86% | +0.58% |
| MRK | Merck & Co. Inc. | +4.07% | +0.55% |
| NVS | Novartis AG | +12.70% | +0.16% |
| TMO | Thermo Fisher Scientific Inc. | +5.61% | +0.11% |
| AMGN | Amgen Inc. | +12.80% | -0.30% |
